Ingenix Acquires QualityMetric, a Health Outcomes Measurement Firm
Ingenix, a health information, technology, consulting and services company, announced that it has expanded its health outcomes measurement capabilities with the acquisition of QualityMetric Incorporated. QualityMetric helps health care companies assess health outcomes as reported by patients themselves, known as patient-reported outcomes.
This acquisition adds a new dimension to the capabilities Ingenix can offer to life sciences companies, governments, health systems, payers and consumers. Patient-reported outcomes (PROs) are an important measure of the ultimate effectiveness of health care. QualityMetric develops and maintains popular general and disease-specific health surveys for measuring patients’ own assessments of their health.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA Issues Complete Response Letter to Replimune for RP1 Combination Therapy in Advanced Melanoma
July 22nd 2025The FDA’s complete response letter cited concerns that the Phase I/II IGNYTE (NCT03767348) trial in advanced melanoma was not an adequate, well-controlled study and that its heterogeneous patient population limited interpretability, preventing approval in its current form.
